chelerythrine has been researched along with bq 123 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bugge, E; Ytrehus, K | 1 |
Alvarez, BV; CamiliĆ³n de Hurtado, MC; Cingolani, HE; Ennis, IL | 1 |
Bevan, JA; Xie, H | 1 |
Apers, S; Caballero-George, C; Claeys, M; Gupta, MP; Pieters, L; Solis, PN; Van den Heuvel, H; Vanderheyden, PM; Vauquelin, G; Vlietinck, AJ | 1 |
Chang, IY; Kim, BJ; So, I | 1 |
5 other study(ies) available for chelerythrine and bq 123
Article | Year |
---|---|
Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Benzophenanthridines; Bosentan; Coronary Circulation; Decanoic Acids; Endothelin Receptor Antagonists; Endothelins; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Peptides, Cyclic; Perfusion; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Sulfonamides | 1996 |
Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system.
Topics: Alkalies; Alkaloids; Amiloride; Angiotensin II; Animals; Anti-Arrhythmia Agents; Autocrine Communication; Benzophenanthridines; Cats; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Heart; Hydrogen-Ion Concentration; Losartan; Muscle Contraction; Muscle Fibers, Skeletal; Oligopeptides; Papillary Muscles; Paracrine Communication; Peptides, Cyclic; Phenanthridines; Protein Kinase C; Sodium-Hydrogen Exchangers | 1998 |
Oxidized low-density lipoprotein enhances myogenic tone in the rabbit posterior cerebral artery through the release of endothelin-1.
Topics: Alkaloids; Animals; Benzophenanthridines; Blood Pressure; Cerebrovascular Circulation; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Oxidation-Reduction; Peptides, Cyclic; Phenanthridines; Posterior Cerebral Artery; Potassium Chloride; Protein Kinase C; Rabbits; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 1999 |
Inhibitory activity on binding of specific ligands to the human angiotensin II AT(1) and endothelin 1 ET(A) receptors: bioactive benzo[c]phenanthridine alkaloids from the root of Bocconia frutescens.
Topics: Alkaloids; Angiotensin II; Animals; Benzophenanthridines; Binding, Competitive; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Isoquinolines; Ligands; Molecular Structure; Papaveraceae; Peptides, Cyclic; Phenanthridines; Plant Extracts; Plant Roots; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptors, Angiotensin; Receptors, Endothelin; Tritium; Tumor Cells, Cultured | 2002 |
Pharmacological differences of endothelin receptors-mediated modulation in cultured interstitial cells of Cajal from the murine small and large intestine.
Topics: Animals; Benzophenanthridines; Calcium; Calcium-Transporting ATPases; Cell Membrane; Cells, Cultured; Endothelin-1; Endothelin-2; Endothelin-3; Interstitial Cells of Cajal; Intestine, Large; Intestine, Small; Membrane Potentials; Mice; Mice, Inbred BALB C; Naproxen; Oligopeptides; Patch-Clamp Techniques; Peptides, Cyclic; Piperidines; Prostaglandin-Endoperoxide Synthases; Protein Kinase C; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Thapsigargin | 2012 |